The Oxford Overview assembles nearly 150 representatives of the world’s leading breast cancer research organizations to review benchmark research in the field of breast cancer. Current modalities of polychemotherapy (using multiple drugs at once), tamoxifen and ovarian ablation/suppression (removing, radiating, or mitigating ovaries with drugs), and radiation therapy have emanated from the Oxford Overview’s broad-based vision. The Overview includes all randomized evidence available, not merely reviews of individuals trials.
“The Overview is a collaborative exercise that reviews data representing over 100,000 women who have participated in clinical trials,” explains Dr.Hyams.“It results in critical publications that identify major trends in breast cancer treatment and outcomes. I am pleased to have had the chance to participate in four of these meetings. It has been a wonderful experience residing in an Oxford College and working with the world’s leading breast cancer physicians. The results of this effort are seminal publications that are among the most quoted in the breast cancer literature. There is no question that the Overview analyses have increased our understanding of where we have come from and where we are going in this rapidly evolving field.”
Subsequent to his September visit to England,Dr.Hyams was an invited lecturer at several regional oncology meetings including the 13th Annual Meeting on Breast Cancer “Developments and Unanswered Questions,” National University of Athens Hospital, Greece, the XIII GERICHO Society Oncology Meeting in Baux de Provence, France, and the International Symposium of Breast Cancer Gene Expression in Rome, Italy.
Dr.Hyams joined the medical staff of Eisenhower Medical Center in 1999.He previously served as Executive Medical Officer of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the nation’s largest breast cancer research group.More recently,Dr. Hyams served as Medical Director of Aptium® Oncology Research Group, a Californiabased research network coordinating national and international oncology studies. Dr.Hyams has remained active in clinical research and is working to develop innovative research initiatives that will better serve the desert community and beyond.